Aldeyra Therapeutics (ALDX) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free ALDX Stock Alerts $3.93 -0.01 (-0.25%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Daybusinesswire.com - April 25 at 7:00 AMAldeyra Therapeutics to Host Research & Development Day on April 25, 2024businesswire.com - April 18 at 7:00 AMAttention Long-Term Aldeyra Therapeutics, Inc. (ALDX) Investors: Grabar Law Office Is Investigating Claims on Your Behalfmarkets.businessinsider.com - April 15 at 8:06 AMAldeyra Therapeutics, Inc (NASDAQ:ALDX) Short Interest Up 12.0% in Marchmarketbeat.com - April 14 at 7:50 AMPerceptive advisors buys Aldeyra Therapeutics shares worth $833kinvesting.com - April 10 at 3:27 PMPerceptive Advisors Llc Purchases 37,712 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stockinsidertrades.com - April 9 at 4:32 AMPerceptive Advisors Llc Buys 37,712 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stockmarketbeat.com - April 8 at 6:40 PMAldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buyingmsn.com - April 4 at 7:45 AMAldeyra Therapeutics, Inc (NASDAQ:ALDX) Major Shareholder Perceptive Advisors Llc Acquires 8,374 Sharesinsidertrades.com - April 4 at 7:09 AMAldeyra Therapeutics, Inc (NASDAQ:ALDX) Major Shareholder Purchases $27,215.50 in Stockmarketbeat.com - April 3 at 6:58 PMAldeyra gains as Oppenheimer upgrades on revised plans for lead assetmsn.com - April 3 at 4:44 PMAldeyra's Dry Eye Disease Drug May Be on Path for FDA Approvalfinance.yahoo.com - April 3 at 4:44 PMAldeyra Therapeutics, Inc. (NASDAQ:ALDX) Is About To Turn The Cornerfinance.yahoo.com - April 3 at 8:43 AMAldeyra Therapeutics (NASDAQ:ALDX) Upgraded at Oppenheimermarketbeat.com - April 3 at 8:17 AMAnalysts Offer Insights on Healthcare Companies: Aldeyra Therapeutics (ALDX), Carisma Therapeutics (CARM) and Panbela Therapeutics (OtherPBLA)markets.businessinsider.com - April 2 at 9:49 AMAldeyra Therapeutics (NASDAQ:ALDX) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - April 2 at 9:12 AMEquities Analysts Offer Predictions for Aldeyra Therapeutics, Inc's FY2028 Earnings (NASDAQ:ALDX)marketbeat.com - March 15 at 5:11 AMAldeyra Therapeutics, Inc (NASDAQ:ALDX) to Post Q1 2024 Earnings of ($0.15) Per Share, HC Wainwright Forecastsmarketbeat.com - March 14 at 6:40 AMAldeyra Therapeutics Inc President and CEO Todd Brady Sells Company Sharesfinance.yahoo.com - March 13 at 8:29 AMBruce Greenberg Sells 13,201 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stockinsidertrades.com - March 13 at 7:20 AMHC Wainwright Comments on Aldeyra Therapeutics, Inc's FY2028 Earnings (NASDAQ:ALDX)marketbeat.com - March 13 at 7:18 AMInsider Selling: Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Insider Sells 13,201 Shares of Stockmarketbeat.com - March 12 at 10:43 PMQ3 2024 Earnings Forecast for Aldeyra Therapeutics, Inc Issued By Leerink Partnrs (NASDAQ:ALDX)marketbeat.com - March 12 at 7:35 AMStrong Buy Rating for Aldeyra Therapeutics Backed by Reproxalap Developments and Strategic Partnershipsmarkets.businessinsider.com - March 11 at 12:20 AMInstitutions own 37% of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares but retail investors control 37% of the companyfinance.yahoo.com - February 22 at 12:49 PMVictory Capital Management Inc. Lowers Holdings in Aldeyra Therapeutics, Inc (NASDAQ:ALDX)marketbeat.com - February 19 at 4:12 AMIntellia Therapeutics, Inc.cnn.com - February 14 at 10:59 AMAldeyra Therapeutics (NASDAQ:ALDX) Stock Price Crosses Above 50-Day Moving Average of $3.24marketbeat.com - February 13 at 5:05 AMAldeyra Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 6 at 9:36 AMLeerink Partnrs Weighs in on Aldeyra Therapeutics, Inc's FY2024 Earnings (NASDAQ:ALDX)marketbeat.com - January 31 at 7:35 AMAldeyra Therapeutics Stock (NASDAQ:ALDX), Guidance and Forecastbenzinga.com - January 31 at 12:40 AMAldeyra Therapeutics, Inc (NASDAQ:ALDX) Expected to Post FY2028 Earnings of $2.55 Per Sharemarketbeat.com - January 30 at 7:16 AMWhy Aldeyra Therapeutics Is A Strong Buy: AbbVie Agreement And Reproxalap's Prospectsseekingalpha.com - January 28 at 8:41 AMAldeyra Therapeutics (NASDAQ:ALDX) Lowered to "Sell" at StockNews.commarketbeat.com - January 20 at 1:22 AMAldeyra Therapeutics, Inc (NASDAQ:ALDX) Short Interest Updatemarketbeat.com - January 13 at 8:15 AMGrabar Law Office Investigates Claims on Behalf of Shareholders of Aldeyra Therapeutics, Inc. (ALDX)markets.businessinsider.com - January 4 at 6:12 PMAldeyra Therapeutics Provides Clinical and Regulatory Update and Announces Advancement of RASP Platform in Systemic and Retinal Inflammatory Diseasesfinance.yahoo.com - January 4 at 8:07 AMStockNews.com Downgrades Aldeyra Therapeutics (NASDAQ:ALDX) to Sellmarketbeat.com - January 4 at 1:22 AMBTIG Reaffirms Their Buy Rating on Aldeyra Therapeutics (ALDX)markets.businessinsider.com - December 31 at 10:39 PMAldeyra Therapeutics (NASDAQ:ALDX) Raised to Hold at StockNews.commarketbeat.com - December 27 at 10:14 PMOutperform Rating Affirmed on Aldeyra Therapeutics Following Positive ADX Developments and Expanding Treatment Prospectsmarkets.businessinsider.com - December 21 at 3:06 PMBuy Rating Affirmed for Aldeyra Therapeutics Amidst Clinical Advancements and Market Potentialmarkets.businessinsider.com - December 21 at 5:05 AMPositive News For Skin Health: Aldeyra Therapeutics' ADX-629 Achieves Key Milestones in Atopic Dermatitis Studymsn.com - December 19 at 6:19 PMAldeyra Therapeutics Shares Rise 12% Following Positive Trial Results of ADX-629marketwatch.com - December 19 at 1:18 PMAldeyra stock jumps 8% on dermatitis drug updatesseekingalpha.com - December 19 at 1:18 PMAldeyra Therapeutics' skin disease drug succeeds in mid-stage studyreuters.com - December 19 at 8:18 AMAldeyra Therapeutics Announces Statistically and Clinically Significant Improvement from Baseline in Phase 2 Clinical Trial of ADX‑629 in Patients with Atopic Dermatitisfinance.yahoo.com - December 19 at 8:18 AMAldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from Phase 2 Clinical Trial of ADX-629 in Patients with Atopic Dermatitisfinance.yahoo.com - December 18 at 8:00 PMAldeyra Therapeutics, Inc (NASDAQ:ALDX) Sees Large Growth in Short Interestmarketbeat.com - December 17 at 9:01 AMAldeyra Therapeutics (ALDX) Price Target Increased by 13.56% to 11.39msn.com - December 16 at 3:23 PM Get Aldeyra Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now ALDX Media Mentions By Week ALDX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALDX News Sentiment▼0.340.33▲Average Medical News Sentiment ALDX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALDX Articles This Week▼33▲ALDX Articles Average Week Get Aldeyra Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CDT News Today OVID News Today VNDA News Today HOWL News Today ACIU News Today GTHX News Today ABEO News Today GALT News Today PBYI News Today DSGN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALDX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aldeyra Therapeutics, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
